UMIN-CTR Clinical Trial

Recruitment status Open public recruiting
Unique ID issued by UMIN UMIN000043900
Receipt No. R000050131
Scientific Title Boring biopsy: A preliminary study of a novel approach to brain biopsy
Date of disclosure of the study information 2021/04/12
Last modified on 2021/04/12 (Ver. 1)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Boring biopsy: A preliminary study of a novel approach to brain biopsy
Acronym Boring biopsy: A preliminary study of a novel approach to brain biopsy
Scientific Title Boring biopsy: A preliminary study of a novel approach to brain biopsy
Scientific Title:Acronym Boring biopsy: A preliminary study of a novel approach to brain biopsy
Region
Japan

Condition
Condition brain tumor
Classification by specialty
Neurosurgery
Classification by malignancy Malignancy
Genomic information NO

Objectives
Narrative objectives1 There are several methods to biopsy intraparenchymal brain lesions, including stereotactic biopsy and open block biopsy, both of which have advantages and disadvantages. We propose a novel biopsy method for intraparenchymal brain lesions, called boring biopsy which aims to overcome the drawbacks of each conventional method. The boring biopsy is minimally invasive and allows continuous specimens of sufficient volume to be obtained. This study aimed to assess the feasibility and efficacy of using boring biopsy for intraparenchymal brain lesions.
Basic objectives2 Safety,Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes The patient- and tumor-related characteristics of interest were sex, age, tumor location, the accuracy of target sampling, histopathology findings, and complications. The accurate biopsy point was defined as the correspondence between the preoperative target point and resected point, based on postoperative magnetic resonance imaging (MRI) or computed tomography (CT) scans.
Key secondary outcomes

Base
Study type Interventional

Study design
Basic design Single arm
Randomization Non-randomized
Randomization unit
Blinding Open -no one is blinded
Control Uncontrolled
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 1
Purpose of intervention Treatment
Type of intervention
Maneuver
Interventions/Control_1 Patients with biopsy for intraparenchymal lesion with boring biopsy method from 7 April 2021 to 31 March 2024
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
16 years-old <=
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria (1) All patients aged 16 years or older who have brain lesions requiring pathological diagnosis and who are judged to be suitable for bowling biopsy (2) Patients for whom written consent was obtained based on the free will of the patient or his / her substitute after receiving sufficient explanation for participation in this study.
Key exclusion criteria (1) Patients judged by the principal investigator to be inappropriate as subjects (2)Patients with hypersensitivity or allergy to nickel titanium alloy
Target sample size 30

Research contact person
Name of lead principal investigator
1st name Toshihiro
Middle name
Last name Ogiwara
Organization Shinshu University School of Medicine
Division name Neurosurgery
Zip code 3908621
Address 3-1-1 Asahi, Matsumoto
TEL 0263372690
Email togiwara@shinshu-u.ac.jp

Public contact
Name of contact person
1st name Toshihiro
Middle name
Last name Ogiwara
Organization Shinshu University School of Medicine
Division name Neurosurgery
Zip code 390-8621
Address Asahi 3-1-1, Matsumoto
TEL 0263372690
Homepage URL
Email togiwara@shinshu-u.ac.jp

Sponsor
Institute Shinshu University School of Medicine
Institute
Department

Funding Source
Organization Grant-in-Aid for Scientific Research
Organization
Division
Category of Funding Organization Japanese Governmental office
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization the Ethics Committee of the Shinshu University School of Medicine
Address 3-1-1 Asahi, Matsumoto
Tel 0263372572
Email mdrinri@shinshu-u.ac.jp

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2021 Year 04 Month 12 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Open public recruiting
Date of protocol fixation
2021 Year 04 Month 12 Day
Date of IRB
2021 Year 04 Month 07 Day
Anticipated trial start date
2021 Year 04 Month 12 Day
Last follow-up date
2024 Year 03 Month 31 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information

Management information
Registered date
2021 Year 04 Month 12 Day
Last modified on
2021 Year 04 Month 12 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000050131